(Q42481723)

1 November 2017

title

Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjects (English)

1 reference

1 November 2017

Heikki Peuravuori

1

1 reference

1 November 2017

Valtteri V Aho

2

1 reference

1 November 2017

Heikki J Aho

3

1 reference

1 November 2017

Yrjö Collan

4

1 reference

1 November 2017

K Matti Saari

5

1 reference

1 November 2017

publication date

26 July 2005

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

1 November 2017

published in

1 reference

1 November 2017

volume

244

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

143-148

1 reference

Extracellular release of bactericidal/permeability-increasing protein in newborn infants

1 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00417-005-0062-Z

Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome

21 January 2018

1 reference

12 December 2020

Immunoglobulins in tears.

1 reference

12 December 2020

Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein

1 reference

12 December 2020

Group IIA phospholipase A2 content of basal, nonstimulated and reflex tears.

1 reference

12 December 2020

Group II phospholipase A2 content of tears in patients with senile cataract and primary open-angle glaucoma

1 reference

12 December 2020

Diurnal variation in group IIa phospholipase A2 content in tears of contact lens wearers and normal controls

1 reference

12 December 2020

Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands

1 reference

12 December 2020

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

1 reference

12 December 2020

Secretion of group 2 phospholipase A2 by lacrimal glands

1 reference

12 December 2020

SDS-Minigel electrophoresis of human tears. Effect of sample treatment on protein patterns

1 reference

12 December 2020

Antimicrobial defensin peptides of the human ocular surface

1 reference

12 December 2020

Detection of natural peptide antibiotics in human nasolacrimal ducts

1 reference

12 December 2020

Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears

1 reference

12 December 2020

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

1 reference

12 December 2020

Lysozyme content of tears in normal subjects and in patients with external eye infections

1 reference

12 December 2020

Role of the bactericidal/permeability-increasing protein in host defence.

1 reference

12 December 2020

Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis sicca.

1 reference

12 December 2020

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria

1 reference

12 December 2020

Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents

1 reference

12 December 2020

Group II PLA(2) content of tears in normal subjects

1 reference

12 December 2020

The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation

1 reference

12 December 2020

Therapeutic potential of the bactericidal/permeability-increasing protein

1 reference

12 December 2020

Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth

1 reference

12 December 2020

10.1007/S00417-005-0062-Z

Identifiers

DOI

1 reference

1 November 2017

1 reference